Zhende Medical(SH:603301) Zheng Quan Zhi Xing·2025-08-01 16:23Meeting Details - The first extraordinary general meeting of shareholders for 2025 will be held in the company's conference room [1] - Voting will be conducted through a combination of on-site and online methods, with specific time slots for each [1][5] - Shareholders registered in the company's records have the right to attend and vote at the meeting [1] Agenda Items - The meeting will review several proposals, including the fourth board of directors' remuneration plan and the cancellation of the supervisory board [3][7] - Other proposals include changes to the company's registered capital, expansion of business scope, and amendments to the company's articles of association [3][7][9] - The company plans to cancel the supervisory board, transferring its powers to the audit committee of the board of directors [7] Financial Proposals - The proposed remuneration for the fourth board of directors is set at RMB 150,000 per year, inclusive of taxes [6] - The company intends to cancel 615,667 shares from the first employee stock ownership plan, reducing the total share capital from 266,451,202 shares to 265,835,535 shares [7][9] Business Scope Changes - The company aims to expand its business scope to include additional medical and healthcare products, such as first-class medical devices and non-medical masks [8][10] - The revised business scope will also cover various manufacturing and sales activities related to personal protective equipment and daily chemical products [9][10] Governance and Compliance - The company will amend its articles of association to reflect changes in governance structure and business operations [10][11] - The amendments will ensure compliance with relevant laws and regulations, enhancing the protection of shareholders' rights [11][12]